Visit the Beamex web site
Click on the advert above to visit the company web site

Product category: Pharmaceutical Processing News
News Release from: Pall | Subject: Ultipor VF UDV20 virus filter
Edited by the Processingtalk Editorial Team on 27 December 2004

Virus filter helps biopharmaceutical
manufacturing

Request your FREE weekly copy of the Processingtalk email newsletter. News about Pharmaceutical Processing News and more every issue. Click here for details.

The introduction of the new Ultipor VF UDV20 virus filter by Pall Corporation will significantly improve the speed, safety and economics of biopharmaceutical manufacturing

New Pall Virus Filter doubles capacity and flow rate to improve biopharmaceutical manufacturing The introduction of the new Ultipor VF UDV20 virus filter by Pall Corporation will significantly improve the speed, safety and economics of biopharmaceutical manufacturing

By combining the Pall proven Ultipor VF DV20 membrane with its high area Ultipleat cartridge, the new UDV20 virus filter offers up to six square meters (6m2) of surface area in a single filter cartridge.

The new design doubles the surface area of the original Ultipor VF DV20 virus filter and does the work of two or more filters without increasing the footprint, complexity or cost of the filter system.

The combination of Ultipleat filter construction with the Ultipor VF DV20 filters proven hydrophilic PVDF (polyvinylidene fluoride) microporous membrane removes viruses as small as 20 nanometers (nm) at twice the speed, maintaining a steady flow rate over time.

The filter removes viruses from biological fluids such as blood fractions, monoclonal antibodies and recombinant proteins, with greater than 95 percent protein transmission, to ensure high purity pharmaceutical drugs with enhanced virus safety.

It has also been shown to remove prion proteins that can cause TSEs (Transmissible Spongiform Encephalopathies), which can result in fatal neurological conditions such as vCJD (variant Creutzfeldt-Jakob Disease), the human form of "mad cow disease".

"By doubling flow rates, the Ultipor VF UDV20 filter can help drug manufacturers decrease processing time while increasing throughput", says Monica Cardona, Marketing Specialist Pall Corporation.

"This is especially critical for large-scale drug manufacturers since it provides the same degree of virus removal available for small-scale manufacturing, with both ease of use and the simplicity of integrity-testing".

The new filter is available in three cartridge sizes: 10-inch (2m2 of surface area), 20-inch (4m2), or 30-inch (6m2).

It can be used in a stainless steel housing or within Kleenpak Nova single-use capsule filter assemblies, giving biopharmaceutical manufacturers all the options they need for their processing scheme.

The Ultipor VF UDV20 filter is 100 percent integrity tested prior to release, and is lot sample challenged for virus retention using PP7 and PR772 bacteriophages.

It can be integrity tested before and after use with the industry proven Forward Flow test.

It is autoclavable, or can be gamma irradiated or in-line steam-sterilised to avoid the need for aseptic installation after sterilisation.

Pall: contact details and other news
Email this article to a colleague
Register for the free Processingtalk email newsletter
Processingtalk Home Page

Search the Pro-Talk network of sites

Visit the Beamex web site